Ischemic heart disease, a narrowing of the arteries supplying blood to the heart, is a leading cause of death throughout the world. A hybrid molecular imaging technique called positron emission tomography and magnetic resonance (PET/MR) imaging, which tells doctors vital information about cardiac and arterial function, has been found to be an effective molecular imaging tool for detecting coronary artery disease (CAD), say researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI).
June 11, 2014 — GE Healthcare introduced its Discovery IQ PET/CT (positron emission tomography/computed tomography) system at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in St. Louis. The system enables both high image quality and intelligent quantitation. It is pending 510(k) clearance from the U.S. Food and Drug Administration (FDA) and not available for sale in the United States.
June 11, 2014 — VuCOMP Inc. announced it has received U.S. Food and Drug Administration (FDA) approval for M-Vu CAD for mammography version 3.1. Concurrently, VuCOMP is releasing an update to its CAD (computer-aided detection) station, which includes the ability to process additional standard screening views.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
June 11, 2014 — Erasmus University Medical Center (Erasmus MC) in Rotterdam, the Netherlands, announced the purchase of Elekta Versa HD linear accelerators (linacs) and a software upgrade including the Mosaiq oncology information system (OIS) and Monaco 5 treatment planning system.
Many people develop depression in the latest stages of life, but until now doctors had no idea that it could point to a build up of a naturally occurring protein in the brain called beta-amyloid, a hallmark of Alzheimer’s disease. In fact, late-life depression could become a major risk factor for developing Alzheimer’s faster than others, according to research unveiled at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI).
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
With a new molecular imaging system powerful enough to peer down to 20-micrometer resolution, researchers can now use radioluminescence to examine the characteristics of single, unconnected cells. The result is a fascinating picture of diversity among cells previously assumed to behave the same, revealed researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI).
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Taking their pick, biomedical researchers can now conduct five different imaging studies in one scan with a state-of-the-art preclinical molecular imaging system that scientists unveiled during the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting.
Advanced cancer of the neuroendocrine system can lead to dismal prognoses, but a novel therapy is packing a punch by uniting powerful radionuclide treatment and chemotherapy drugs, revealed researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting.
Low back pain is not only excruciating but also debilitating for countless sufferers. Unfortunately, not everyone responds to treatment. A molecular imaging scan in addition to a conventional bone scan can provide the necessary information about the physiological health of the spine to select the most appropriate pain-killing treatment protocol, say researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI).
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
June 9, 2014 — Toshiba America Medical Systems Inc. announced the release of its Celesteion system for positron emission tomography/computed tomography (PET/CT) imaging. The Celesteion is currently pending 510(k) clearance from the U.S. Food and Drug Administration (FDA).
June 9, 2014 — After conducting a functional magnetic resonance imaging (fMRI) study on memory and categorization, researchers have shown for the first time that these mathematical models seem to correctly explain processing in the medial temporal lobes, a region of the brain associated with long-term memory that is disrupted by memory disorders like Alzheimer’s disease. The findings were published in The Journal of Neuroscience.
The prominent role a single enzyme plays in cancer imaging has eluded researchers for years, but not anymore. This discovery could pave new avenues in nuclear medicine.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
June 9, 2014 — ImaginAb Inc., in collaboration with Memorial Sloan-Kettering Cancer Center, will present at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) initial clinical data with an anti-PSMA (prostate-specific membrane antigen) recombinant antibody fragment (a "minibody") derived from the huJ591 monoclonal antibody, in patients with metastatic prostate cancer.
At the 2014 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 7-11, at the St. Louis Convention Center, Siemens Healthcare will debut syngo.via for molecular imaging — a reading solution that transforms large amounts of data into comprehensive results, allowing for organ-based reading [1], reference-based quantification [2] and evidence-based reporting [3] of disease.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
At the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE Healthcare introduced its Discovery* IQ^ PET/CT (positron emission tomography/ computed tomography) system enabling both outstanding image quality and intelligent quantitation, helping physicians to deliver the best possible patient outcomes.
A study of concussion patients using diffusion tensor imaging (DTI) found that males took longer to recover after concussion than females did. Results of the study, which show that DTI can be used as a bias-free way to predict concussion outcome, are published online in the journal Radiology.
Among the collection of aspiring medical isotope production companies looking to build facilities in the United States, Coquí RadioPharmaceuticals Corp. is he only one using a design and production method already proven in the commercial markets. Coquí is planning on constructing and operating a dedicated medical isotope production facility.
June 6, 2014 — Harvey L. Neiman, M.D., FACR, former chief executive officer of the American College of Radiology (ACR), died June 5 following a long illness. Neiman was widely considered a medical visionary who dedicated his professional life to improving patient care. “ACR members and staff, the radiology community, and organized medicine have lost a dear friend and colleague, exceptional leader, mentor and luminary,” said Bibb Allen, Jr., M.D., FACR, chair of the American College of Radiology Board of Chancellors.
June 5, 2014 — Magnetic resonance-guided focused ultrasound (MRgFUS) using the Exablate system by Insightec Ltd. (based in Tirat Carmel, Israel) is a relatively new noninvasive thermal ablation option, U.S. Food and Drug Administration (FDA)-approved for treating and palliating pain from bone metastases. The technology integrates high-intensity focused ultrasound and a real-time magnetic resonance imaging (MRI) system in one unit.
June 5, 2014 — The American Society for Radiation Oncology (ASTRO) has garnered a record-breaking total of 2,874 abstracts submitted for selection for the 56th annual meeting. The scientific presentations will include up to four plenary papers, 360 oral presentations, 1,862 posters and 144 digital posters in more than 50 educational sessions and for 20 disease-site tracks and topics including radiation biology, radiation physics, palliative care, patient safety and patient-reported outcomes.